{"title":"Chest X-Ray Scoring System in COVID-19 Pneumonia: An Added Value in the Evaluation of the Disease Severity","authors":"M. Fogante","doi":"10.14744/ejmo.2021.70171","DOIUrl":null,"url":null,"abstract":"Objectives: To analyze the added value of a new CXR scoring system in the evaluation of the COVID-19 pneumonia severity. Methods: This retrospective study included, from March to April 2020, 169 (132M/37F) hospitalized COVID-19 patients, mean age 65.6±10.8 years;57 had low-pressure ventilation (Group A), 50 positive-pressure ventilation (Group B) and 62 invasive ventilation (Group C). Two radiologists in consensus evaluated the CXRs using an 18-points scoring system. CXR scores were compared in each Group and among the three Groups. Then in each Group CXR scores were correlated with Pa02/Fi02 and, in Group C, with Simplified Acute Physiology Score (SAPS). Non-parametric tests were used. Results: In Group A the median score at admission was 8 [Interquartile range (IR) 7-9] and the median of the highest scores was 9 [IR 8-10](p=0.0738). Median scores at admission and before the start of the ventilation (pre-ventilation) are resulted, in Group B, 10 [IR 8-10] and 11 [IR 10-14](p<0.0001) and, in Group C, 10 [IR 8-11] and 12 [IR 11-13](p<0.0001). In Group A the CXR scores at admission were lower than in Group C (p=0.0257), and the highest scores were lower than the pre-ventilation ones of Groups B (p=0.0018) and C (p=0.0001). The CXR scores correlated negatively with Pa02/Fi02 and positively with SAPS. Conclusion: CXR scoring system could be an added value in the evaluation of COVID-19 pneumonia severity. With lowpressure ventilation, the CXR scores were lower than with positive-pressure and invasive ventilation. Furthermore, CXR scores showed negative correlation with Pa02/Fi02 and positive with SAPS. Implications for practice: This new CXR scoring system could be a useful diagnostic tool to quantify the COVID-19 pneumonia severity and to guide to choice of the correct ventilation support. © 2021 by Eurasian Journal of Medicine and Oncology.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"54 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2021.70171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
新型冠状病毒肺炎胸片评分系统:疾病严重程度评价的附加价值
目的:分析一种新的CXR评分系统在评估COVID-19肺炎严重程度中的附加价值。方法:回顾性研究纳入2020年3月至4月住院的新冠肺炎患者169例(132M/37F),平均年龄65.6±10.8岁,其中低压通气57例(A组),正压通气50例(B组),有创通气62例(C组)。两位放射科医师一致采用18分制对cxr进行评估。比较各组及三组间的CXR评分。然后各组CXR评分与Pa02/Fi02相关,C组与简化急性生理评分(SAPS)相关。采用非参数检验。结果:A组患者入院时评分中位数为8[四分位间距(IR) 7 ~ 9],最高评分中位数为9 [IR 8 ~ 10](p=0.0738)。入院时和通气(预通气)开始前的中位评分,B组为10 [IR 8-10]和11 [IR 10-14](p<0.0001), C组为10 [IR 8-11]和12 [IR 11-13](p<0.0001)。A组患者入院时CXR评分低于C组(p=0.0257),最高评分低于B组(p=0.0018)和C组(p=0.0001)。CXR评分与Pa02/Fi02呈负相关,与SAPS呈正相关。结论:CXR评分系统可作为评估COVID-19肺炎严重程度的一种附加价值。低压通气组的CXR评分低于正压通气组和有创通气组。此外,CXR评分与Pa02/Fi02呈负相关,与SAPS呈正相关。实践意义:这种新的CXR评分系统可能是量化COVID-19肺炎严重程度和指导选择正确通气支持的有用诊断工具。©2021 by Eurasian Journal of Medicine and Oncology。
本文章由计算机程序翻译,如有差异,请以英文原文为准。